Moderna (NasdaqGS:MRNA) received FDA approval for updated Spikevax and mNEXSPIKE COVID-19 vaccines tailored to the latest SARS-CoV-2 subvariant. The FDA also cleared mFlusiva, Moderna's first mRNA based influenza vaccine for adults aged 50 and over. These approvals expand Moderna's respiratory vacc…
ONLY AVAILABLE IN PAID PLANS
President Donald Trump appears to be very nervous about the midterms, as officials in the White House have started talking to the Justice Department about who…
A football player of William Jewell College passed away on Saturday following his collapse on the sidelines of the school’s season-opener game just minutes aft…
MercadoLibre (MELI) is back in focus after fresh comparisons with Amazon.com highlighted its role in Latin American e-commerce and fintech, prompting investors…
Boeing (NYSE:BA) appoints Ryan L. Shedd as Senior Vice President and Controller, succeeding retiring executive Michael J. Cleary. The leadership change reshape…
It has been just a couple of months since Toby Weiss took over as the CEO of enterprise cybersecurity software company Securonix, headquartered in Texas. He ha…
Event driven interest in TIC Solutions stock TIC Solutions (TIC) is back in focus after recent acquisitions of we-do-IT, GeoVerra Holdings and Core Group, with…